WARRICK 1621
Pill imprint WARRICK 1621 has been identified as Griseofulvin, ultramicrocrystalline ultramicrocrystalline 250 mg.
Griseofulvin is used in the treatment of tinea capitis; tinea cruris; dermatophytosis; tinea corporis; onychomycosis, toenail (and more), and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy.
Griseofulvin ultramicrocrystalline 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Griseofulvin, ultramicrocrystalline Images
- Imprint:
-
WARRICK
1621 - Strength:
- ultramicrocrystalline 250 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- ESI Lederle Generics
Advertisement
More Griseofulvin, Ultramicrocrystalline resources
- Griseofulvin Microsize Oral Suspension (Wolters Kluwer)
- Griseofulvin Microsize Tablets (Wolters Kluwer)
- Griseofulvin Ultramicrosize Tablets (Wolters Kluwer)
- griseofulvin (Cerner Multum)
- griseofulvin (Micromedex) - Includes Dosage Information
- Griseofulvin (AHFS DI)
- Griseofulvin (FDA)
Search Again
